Intelligence · Clinical Pipeline
Oncology · Phase III
Oncology programs at Phase III — ClinicalTrials.gov pipeline intelligence.
- Programs
- 1,266
Quick answer
Oncology Phase III programs: NovaPharmaNews indexes 1,266 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- AstraZeneca 75 programs
- Chinese Academy of 70 programs
- HOFFMANN-LA ROCHE 68 programs
- MSD Merck Sharp 56 programs
- First People's Hospital 53 programs
- Ningbo Cancer Hospital 44 programs
- United Therapeutics Europe 43 programs
- Anaxis Pharma 37 programs
- AstraZeneca 37 programs
- Novartis India 32 programs
- George Institute for 29 programs
- Takeda 28 programs
-
robot-assisted surgery
Hospital Authority, Hong Kong
Rectal Cancer
1 trial -
serplulimab、bevacizumab
Changhai Hospital
Rectal Cancer
1 trial -
six courses of zanubrutinib, rituximab and lenalidomide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diffuse Large B-Cell Lymphoma
1 trial -
sunitinib malate
Pfizer
Carcinoma, Hepatocellular
1 trial -
talazoparib plus enzalutamide
Pfizer
Prostate Cancer
1 trial -
tissue-of-origin (ORIGIN-PanCA○R) profiling
Fudan University
Cancer of Unknown Primary Site
1 trial -
toripalimab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Esophageal Cancer
1 trial -
trastuzumab
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
trifluridine/tipiracil
Takeda
Metastatic Oesogastric Adenocarcinoma
1 trial -
trofosfamide, idarubicin, etoposide
Solid Biosciences
Soft Tissue Sarcoma
1 trial -
venetoclax
The First People's Hospital of Lianyungang
Acute Promyelocytic Leukemia
1 trial -
vinflunine
Pierre Fabre Medicament
Breast Cancer
1 trial -
volrustomig
AstraZeneca
Locally Advanced Head and Neck Squamous Cell Carcinoma
1 trial -
volrustomig, KEYTRUDA 25 mg/mL concentrate for solution for infusion, Carboplatin Hikma 10 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Paclitaxel Bendalis 6 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Pemetrexed Accord 25 mg/ml concentrate for solution for infusion, Mycofit, 250 mg, kapsułki twarde, Remsima 100 mg powder for concentrate for solution for infusion
AstraZeneca AB
Metastatic Non-Small Cell Lung Cancer (mNSCLC)
1 trial -
xevinapant, Xevinapant Placebo
Merck Sharp and Dohme
Resected squamous cell carcinoma of the head and neck
1 trial -
zanubrutinib
BEONE MEDICINES AUS PTY LTD
Mantle Cell Lymphoma; Non-Hodgkin Lymphoma
1 trial -
zongertinib
Boehringer Ingelheim
Lung Cancer, Non-squamous, Non-small Cell
1 trial -
Placebo to Osimertinib - Film-coated tablet - 40mg / 80mg, CARBOPLATIN, TAGRISSO 80 mg film-coated tablets, CISPLATIN, PEMETREXED, PEMETREXED, TAGRISSO 40 mg film-coated tablets
AstraZeneca AB
Non-Small Cell Lung Cancer
1 trial
Frequently asked questions
How many oncology Phase III programs exist?
1,266 programs match both the therapeutic area and stage filters in our published index.
Data attribution: Data sources · All pipeline programs